LAMIVIR (Lamivudine) is a prescription antiviral medication used to treat both HIV and hepatitis C infections. Its primary function is to inhibit viral replication, reducing the amount of virus in the body and helping to manage disease progression effectively. For patients in the United States, the United Kingdom, and Canada, LAMIVIR offers a reliable option for controlling viral infections and supporting long-term immune health.
The active ingredient, lamivudine, works by blocking the activity of viral enzymes essential for the virus to multiply. This prevents further infection of healthy cells and helps maintain a lower viral load, which is critical for reducing complications associated with HIV and hepatitis C. LAMIVIR is most effective when taken consistently as prescribed by a qualified healthcare professional.
Available in convenient tablet form, LAMIVIR can be easily incorporated into daily treatment routines. Patients are advised to follow their doctor’s instructions carefully to ensure optimal efficacy and avoid the risk of drug resistance. With proper medical supervision, LAMIVIR helps improve quality of life by controlling infection and supporting overall immune system function.
Whether used as part of combination therapy for HIV or in hepatitis C treatment plans, LAMIVIR (Lamivudine) remains a trusted medication for managing viral infections safely and effectively.